首页> 美国卫生研究院文献>Pediatric Reports >Autologous adipocyte graft in endoscopic treatment of vesico-renal reflux in children: a preliminary study
【2h】

Autologous adipocyte graft in endoscopic treatment of vesico-renal reflux in children: a preliminary study

机译:自体脂肪细胞移植在内窥镜治疗儿童膀胱肾返流中的初步研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

No bulking agent is ideal for endoscopically treating vesico-renal reflux in children. Many teams have tried to find a safe and efficient material, ideally an autologous material. We describe here a protocol for the use of autologous viable fat in the treatment of primary vesico-renal reflux in children aged from 3 to 15 years. Fat harvesting was done from the medial side of the thigh by manual aspiration. Samples were centrifuged to purify the graft from blood and lipid. Lastly fat was injected beneath the pathologic ureter by a conventional endoscopic technique. A voiding cystourethrography (VCUG) closed the procedure. Follow-up included renal ultrasonography the day after surgery, and one and three months later. A VCUG was performed systematically at three months and, in cases of acute pyelonephritis, during the survey.Sixty-four children with 94 refluxing units were treated by autologous fat injection with a follow-up from 6 to 40 months. At the end of the procedure, we systematically obtained a very good increase in height of the pathologic meatus and VCUG was normal in all cases. None presented with an obstruction during the follow-up period. Two children presented with an acute pyelonephritis before the third month. At three months, VCUG was not realized in 14 cases (22%) because the parents refused the procedure. One of those children presented with an acute pyelonephritis five months after endoscopic treatment. VCUG was normal for 17 of 50 children (34%), and showed a real improvement for 19 other children (38%). Three children had a surgical reimplantation because of the persistence of an unchanged high-grade vesico-renal reflux; histological examination found viable adipocytes on sections of the distal pathologic ureter. Clinically, 11 children (17%) presented with an acute pyelonephritis after treatment at a mean follow-up time of 10 months.These preliminary findings led us to modify the technique in order to improve our results. Our first concern is feasibility and safety of this technique, regardless of the use of other synthetic bulking agents the innocuousness of which is uncertain.
机译:没有填充剂是内窥镜治疗儿童膀胱肾返流的理想选择。许多团队试图找到一种安全有效的材料,理想情况下是自体材料。我们在这里描述了一种使用自体活脂肪治疗3至15岁儿童原发性膀胱肾返流的方案。通过手动抽吸从大腿内侧收获脂肪。离心样品以从血液和脂质中纯化移植物。最后,通过常规内窥镜技术将脂肪注射到病理输尿管下方。膀胱膀胱排尿描记术(VCUG)结束了手术。随访包括术后第二天,一个月和三个月后的肾脏超声检查。在调查的三个月中系统地进行了VCUG,在急性肾盂肾炎的情况下进行了调查。对64例具有94个回流单元的儿童进行了自体脂肪注射治疗,随访6至40个月。在手术结束时,我们系统地获得了很高的病理性鼻孔高度,并且在所有情况下VCUG均正常。在随访期间,没有人出现阻塞。两个孩子在第三个月前出现急性肾盂肾炎。在三个月的时间里,有14例(22%)未实现VCUG,因为父母拒绝了该程序。在内窥镜治疗五个月后,其中一名儿童患有急性肾盂肾炎。 50名儿童中有17名(34%)的VCUG正常,而其他19名儿童(38%)的VCUG有所改善。由于顽固性高级别的膀胱肾返流的持续存在,三个孩子再次手术。组织学检查发现在远端病理输尿管的切片上有存活的脂肪细胞。临床上有11名儿童(17%)在接受治疗后出现了急性肾盂肾炎,平均随访时间为10个月。这些初步发现促使我们对技术进行了改进,以改善治疗效果。我们首先要考虑的是这项技术的可行性和安全性,而与使用其他合成填充剂(其无毒性尚不确定)无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号